Fachliteratur Gastroenterologie: Neoplasien der Gallenwege

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie

15. September 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Fachliteratursuche

Gallenwege

Cholezystitis - Cholelithiasis

Schrift:

Seite 1 von 821


	Artikel 1 - 20 / 16418

	Gallbladder Squamous Cell Carcinoma with Diffuse Î²-hCG Expression: A Case Report and Review of the Literature. J Gastrointest Cancer He S, Bosch DE, Hemming A. PMID: 40921875 [PubMed - indexed for MEDLINE]
	Emerging HER2 Targeting Immunotherapy for Cholangiocarcinoma. Oncol Res Sungwan P, Panaampon J, Sumankan R, Aoki G, Okada S. PMID: 40918454 [PubMed - indexed for MEDLINE]
	Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context. Front Immunol Li S, Wang Y, Yang D. PMID: 40918092 [PubMed - indexed for MEDLINE]
	A survival prediction model for biliary tract cancer based on least absolute shrinkage and selection operator-cox regression. Ann Med Fan S, Zhao K, Liang Z, Ge Y. PMID: 40899447 [PubMed - indexed for MEDLINE]
	Histopathologic discrepancies between endoscopic forceps biopsy and resection specimens in duodenal papillary lesions: a retrospective study. BMC Gastroenterol Zheng Z, Ding J, Chen Y, Hua H. PMID: 40898095 [PubMed - indexed for MEDLINE]
	Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature. Front Immunol Li X, Wang L, Li S. PMID: 40895533 [PubMed - indexed for MEDLINE]
	Outcomes of stereotactic body radiotherapy for unresectable cholangiocarcinoma: a meta-analysis and systematic review. PeerJ Liu P, Ye H, Song L, Li H, Fu M, Dong Z. PMID: 40895058 [PubMed - indexed for MEDLINE]
	Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma. In Vivo Aydemir E, Yilmaz F, Türkel A, Ate, Do. PMID: 40877181 [PubMed - indexed for MEDLINE]
	Contrast-enhanced ultrasound for diagnosing subtypes of intrahepatic cholangiocarcinoma: a comparative study with poorly differentiated hepatocellular carcinoma. Cancer Imaging Zhang N, Yang Y, Lin K, Qiao B, Yang DP, Jin DD, Li B, Zhao DL, Xie XH, Xie XY, Kang JH, Zhuang BW. PMID: 40866908 [PubMed - indexed for MEDLINE]
	The diverse roles of circular RNAs in cholangiocarcinoma. Med Oncol Zhang Y, Xing X, Liu J, Hou L, Xu Y, Zhai B, Feng H, Guo C, Tan G, Ji D. PMID: 40879959 [PubMed - indexed for MEDLINE]
	A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy. Anticancer Res Kim JH, Yoo C, Jeong H, Cheon J, Kim KP, Ryoo BY, Chang HM, Oh CR, Ryu HW, Park I. PMID: 40877003 [PubMed - indexed for MEDLINE]
	Primary Intrahepatic Biliary Neuroendocrine Neoplasms: A Case Report and Literature Review. J Gastrointest Cancer Chen Z, Hu L, Guo Z, Chu J, He T, E C, Jiang T. PMID: 40875127 [PubMed - indexed for MEDLINE]
	Cholecystitis and cholangiocarcinoma: a two-sample Mendelian randomization study. BMC Gastroenterol Gao X, Gao H, Wang S, Tang F, Zhao Y, Li Y. PMID: 40859233 [PubMed - indexed for MEDLINE]
	Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma. Hepatol Commun Xia JY, Komanduri S, Keswani RN, Rodrigues TR, Sinha J, Rengarajan A, Tran P, Hepler C, Prindle A, Aadam AA. PMID: 40857390 [PubMed - indexed for MEDLINE]
	Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis. Liver Int Altenmüller J, Wiegard C, Sebode M, Lohse AW, Villard C, Kechagias S, Nilsson E, Rorsman F, Marschall HU, Jokelainen K, Bergquist A, Färkkilä M, Schramm C. PMID: 40856347 [PubMed - indexed for MEDLINE]
	Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study. Liver Int Niger M, Rimini M, Castet F, Melzer A, Rizzato MD, Pressiani T, Lavacchi D, Aprile G, Angela T, Saladino T, Silvia N, Cito P, Pastorino A, Terán-Brage E, Sciortino C, Camera S, Pircher C, Persano M, Mazzaferro V, Foti S, Vega KS, Ettrich TJ, Antonuzzo L, Rimassa L, Lonardi S, Perkhofer L, Macarulla T, Pietrantonio F, Casadei-Gardini A. PMID: 40856270 [PubMed - indexed for MEDLINE]
	Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies. Front Immunol Xue J, Zhang L, Zhang K, Zhou K, Zhao H. PMID: 40861435 [PubMed - indexed for MEDLINE]
	A Medical Anthropology Assessment of Community Liver Cancer Risks: Qualitative Comparisons of Communities with Different Risk Profiles in Thailand. Asian Pac J Cancer Prev Loffredo CA, Navasumrit P, Pupacdi B, Rabibhadana S, Phornphutkul K, Harris C, Wang XW, Ruchirawat M, Wang JH. PMID: 40849700 [PubMed - indexed for MEDLINE]
	The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis. Asian Pac J Cancer Prev Syarifuddin E, Aryanti C. PMID: 40849693 [PubMed - indexed for MEDLINE]
	First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study. Signal Transduct Target Ther Shi G, Huang X, Ma L, Li H, Zhong J, Wang J, Gao Q, Guo X, Qiu S, Sun H, Shi Y, Huang X, Wang X, Yi Y, Zhu X, Huang C, Ding Z, Chen Y, He Y, Shen Y, Sun Q, Zhou J, Fan J. PMID: 40835595 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 16418

Seite 1 von 821



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung